Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-27 @ 9:52 PM
Study NCT ID:
NCT06046495
Status:
RECRUITING
Last Update Posted:
2025-04-23
First Post:
2023-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Sponsor:
Avistone Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-08
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-06
First Submit QC Date:
None
Study First Post Date:
2023-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-21
Last Update Post Date:
2025-04-23
Last Update Post Date Type:
ACTUAL